The Association Between Vitamin D and Type 2 Diabetes Mellitus Complicated with Non-Alcoholic Fatty Liver Disease: An Observational Cross-Sectional Study
Yuling Xing,Tiantian Cheng,Fei Zhou,Huijuan Ma
DOI: https://doi.org/10.2147/DMSO.S348870
2022-02-02
Abstract:Yuling Xing, 1, 2 Tiantian Cheng, 1, 3 Fei Zhou, 1, 2 Huijuan Ma 1, 4, 5 1 Department of Endocrinology, Hebei General Hospital, Shijiazhuang, 050017, People's Republic of China; 2 Graduate School of Hebei Medical University, Shijiazhuang, 050017, People's Republic of China; 3 Department of Internal Medicine, School of Clinical Medicine, North China University of Science and Technology, Tangshan, 063210, Hebei, People's Republic of China; 4 Hebei Key Laboratory of Metabolic Diseases, Hebei General Hospital Shijiazhuang, Hebei, 050051, People's Republic of China; 5 Department of Internal Medicine, Hebei Medical University, Shijiazhuang, Hebei, 050017, People's Republic of China Correspondence: Huijuan Ma, Email Objective: To investigate the association between vitamin D deficiency and NAFLD risk in patients with type 2 diabetes mellitus (T2DM). Methods: Overall, 434 patients with T2DM admitted to Hebei General Hospital from January 2019 to December 2019 were selected as the study subjects. According to abdominal ultrasound findings, patients were divided into the NAFLD group and the non-NAFLD group. Participants were divided into two study groups according to the 25-hydroxyvitamin D [25(OH)D] level. 25(OH)D deficiency was defined if 25(OH)D vitamin levels were 23kg/m 2 , but not those with BMI ≤ 23kg/m 2 . The significant correlation between vitamin D deficiency and NAFLD was found in participants with BMI > 23kg/m 2 , age ≤ 65 years, without hypertension, TG 23kg/m 2 were more susceptible to NAFLD by vitamin D deficiency and that it is necessary to maintain optimal serum vitamin D levels in this population. Keywords: type 2 diabetes mellitus, non-alcoholic fatty liver disease, vitamin D Non-alcoholic fatty liver disease (NAFLD) was characterized by a spectrum of pathologies ranging from simple hepatocyte steatosis to non-alcoholic steatohepatitis (NASH). As the disease progresses, it can lead to liver cirrhosis and even the liver cancer. 1 In a recent meta-analysis of 86 studies, the global prevalence of NAFLD was estimated to be 25.24% in the general population, while several meta-analyses indicated that in type 2 diabetes mellitus (T2DM) patients the prevalence was double (54–59.67%). 2–4 The prevalence of NAFLD has reached as high as 90%, particularly in T2DM patients with obesity. 5 However, accumulating evidence indicated that the effects of NAFLD extend beyond the liver and are negatively associated with a range of chronic diseases, most notably cardiovascular disease (CVD), T2DM and chronic kidney disease (CKD). 6 However, there was no definitive treatment for NAFLD other than lifestyle intervention. 7 Vitamin D was a lipid-soluble vitamin involved primarily in bone metabolism, calcium and phosphate homeostasis and skeletal development. 8 25-Hydroxyvitamin D [25(OH)D] was the active form of vitamin D. 9 The evaluation of vitamin D status usually relied on detection of the serum 25(OH)D concentration. 10 Several epidemiologic studies show that low serum levels of 25(OH)D were associated with adverse health outcomes, such as metabolic syndrome, diabetes, chronic liver disease, cancer, cardiovascular disease and all-cause mortality. 11–16 Worldwide, vitamin D deficiency was one of the most important public health issues and its prevalence in general populations is approximately 36% in the United States, 61% in Canada, 92% in Northern Europe, 45–98% in Asia, 31% in Australia and 56% in New Zealand. 17 A meta-analysis concluded that vitamin D deficiency was common in Asia based on data from -Abstract Truncated-
endocrinology & metabolism